Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLK1 | P53350 | 1/20 | 0.45 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | CA4 | P22748 | 1/20 | 0.43 |
| ▸ | CA6 | P23280 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18230845 | 0.86 | POLB (0.51) | SMN1; SMN2ALDH1A1KDM4EHPGDNAPRT | |
| SCHEMBL2965336 | 0.85 | HNF4A (0.50) | SMN1; SMN2ALDH1A1KDM4EHPGDPOLB | |
| SCHEMBL10732738 | 0.79 | RAB9A (0.50) | SMN1; SMN2ALDH1A1CA12CA1CA2 | |
| 1,5-Pentanediol SCHEMBL18191835 | 0.77 | ALDH1A1 (0.46) | SMN1; SMN2ALDH1A1KDM4EHPGDPOLB | |
| SCHEMBL9958891 | 0.77 | POLB (0.60) | ALDH1A1KDM4EHPGDPOLBMAPT | |
| SCHEMBL5530486 | 0.77 | ALDH1A1 (0.50) | HCAR2SMN1; SMN2ALDH1A1KDM4ECA12 | |
| SCHEMBL8773868 | 0.76 | ALB (0.47) | SMN1; SMN2ALDH1A1KDM4EPOLBMAPT | |
| SCHEMBL4397955 | 0.76 | PTPN11 (0.50) | PLK1SMN1; SMN2ALDH1A1KDM4ECA12 | |
| SCHEMBL20853618 | 0.75 | KCNQ2 (0.42) | PLK1HCAR2SMN1; SMN2ALDH1A1KDM4E | |
| SCHEMBL30195450 | 0.74 | PTPN11 (0.58) | PLK1SMN1; SMN2ALDH1A1KDM4ECA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 520 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4743051-A1 | 3-HYDROXYPROPYLESTERS AS SOLUBILITY ENHANCERS FOR LIPOPHILIC INGREDIENTS | Symrise AG (DE) | 2026-05-20 | — | — | EP | claimed |
| US-12576018-B2 | Active agents for skin and hair care with sensory modifying properties | SYMRISE AG (DE) | 2026-03-17 | — | — | US | claimed |
| EP-4110276-B1 | COMPOSITIONS COMPRISING ALKANEDIOLS | SYMRISE AG (DE) | 2026-01-28 | — | — | EP | claimed |
| US-20250255833-A1 | Compositions Comprising One or More (Bio)-Alkanediols with Antioxidants | SYMRISE AG (DE) | 2025-08-14 | — | — | US | claimed |
| EP-4565194-A1 | ODOR AND COLORANT STABILIZED COMPOSITIONS | Symrise AG (DE) | 2025-06-11 | — | — | EP | claimed |
| US-12303468-B2 | Compositions comprising one or more (bio)-alkanediols with antioxidants | SYMRISE AG (DE) | 2025-05-20 | — | — | US | claimed |
| EP-4545065-A2 | COMPOSITIONS COMPRISING ONE OR MORE (BIO)-ALKANEDIOLS WITH ANTIOXIDANTS | Symrise AG (DE) | 2025-04-30 | — | — | EP | claimed |
| EP-4110477-B1 | COMPOSITIONS COMPRISING ONE OR MORE (BIO)-ALKANEDIOLS WITH ANTIOXIDANTS | SYMRISE AG (DE) | 2025-03-19 | — | — | EP | claimed |
| WO-2025011745-A1 | 3-HYDROXYPROPYLESTERS AS SOLUBILITY ENHANCERS FOR LIPOPHILIC INGREDIENTS | SYMRISE AG (DE) | 2025-01-16 | — | — | WO | claimed |
| EP-4477264-A2 | COMPOSITIONS COMPRISING ONE OR MORE (BIO)-ALKANEDIOLS WITH ACTIVE INGREDIENTS | Symrise AG (DE) | 2024-12-18 | — | — | EP | claimed |
| US-20160184205-A1 | OXIDATIVE DYEING COMPOSITION | KAO GERMANY GMBH (DE) | 2016-06-30 | — | — | US | claimed |
| WO-2015180740-A1 | OXIDATIVE DYEING COMPOSITION | KAO GERMANY GMBH (DE) | 2015-12-03 | — | — | WO | claimed |
| US-20150118334-A1 | TOPICAL COMPOSITIONS FOR THE TREATMENT OF CHRONIC INFLAMMATORY SKIN DISEASE | KAMEDIS LTD. (IL) | 2015-04-30 | — | — | US | claimed |
| EP-2861239-A2 | TOPICAL COMPOSITIONS FOR THE TREATMENT OF CHRONIC INFLAMMATORY SKIN DISEASE | Kamedis Ltd. (IL) | 2015-04-22 | — | — | EP | claimed |
| WO-2014041542-A2 | TOPICAL COMPOSITIONS FOR THE TREATMENT OF ACNE | KAMEDIS LTD (IL) | 2014-03-20 | — | — | WO | claimed |
| WO-2014030155-A2 | TOPICAL COMPOSITIONS FOR THE TREATMENT OF PSORIASIS AND SEBORRHEA | KAMEDIS LTD (IL) | 2014-02-27 | — | — | WO | claimed |
| WO-2013190548-A2 | TOPICAL COMPOSITIONS FOR THE TREATMENT OF CHRONIC INFLAMMATORY SKIN DISEASE | KAMEDIS LTD (IL) | 2013-12-27 | — | — | WO | claimed |
| US-20120276033-A1 | Temperature Management Composition | KIMBERLY-CLARK WORLDWIDE, INC. | 2012-11-01 | — | — | US | claimed |
| WO-2012146994-A2 | TEMPERATURE MANAGEMENT COMPOSITION | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2012-11-01 | — | — | WO | claimed |
| EP-2494973-A1 | Topical compositions for the treatment and prevention of skin diseases, in particular radiation dermatitis caused by ionising radiation | Sinerga Group S.r.l. (IT) | 2012-09-05 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250255833-A1 | Compositions Comprising One or More (Bio)-Alkanediols with Antioxidants | MMP8, CXCL8, IL18 | PLK1 4848/4885HCAR2 96/4885SMN1; SMN2 3618/4885 |
| US-20160184205-A1 | OXIDATIVE DYEING COMPOSITION | POR, CYP4A22, CYP3A43 | PLK1 4429/4885HCAR2 1547/4885SMN1; SMN2 4655/4885 |
| US-12303468-B2 | Compositions comprising one or more (bio)-alkanediols with antioxidants | MMP8, CXCL8, IL18 | PLK1 4848/4885HCAR2 96/4885SMN1; SMN2 3618/4885 |
| US-12576018-B2 | Active agents for skin and hair care with sensory modifying properties | SCD5, SMURF1, SGMS1 | PLK1 3961/4885HCAR2 1434/4885SMN1; SMN2 3245/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.